logo
Mozart chocolate row leaves bitter taste in Austria

Mozart chocolate row leaves bitter taste in Austria

Yahoo04-05-2025
At a small high-end confectionery in Vienna, chefs put the finishing touches to one of Austria's signature souvenirs: Mozart chocolate balls filled with marzipan, pistachio, and rich almond and hazelnut nougat.
Family-owned Leschanz still painstakingly makes the Mozartkugel chocolates by hand before putting them in their signature wrapping, featuring a portrait of Austria's 18th-century composer Wolfgang Amadeus Mozart.
But Leschanz is in the minority these days, and with the number of brands rising, the chocolate balls beloved by tourists and locals alike are often no longer even produced in Austria.
US food giant Mondelez, which owns one of the most recognisable brands, moved its production from the Austrian city of Salzburg -- Mozart's birthplace -- to Eastern Europe last month, reigniting a heated and long-running marketing debate.
"It's a shame, because Mozart balls are an Austrian product," head confectioner and owner Wolfgang Leschanz, 75, told AFP.
At his firm, 10 time-honoured steps are required to make one single Mozartkugel and about 20,000 of the delicacies are freshly made to order each year.
- Only one 'original' -
Invented by confectioner Paul Fuerst in Salzburg in 1890, the Mozartkugel became popular in Europe after winning a gold medal at a Paris food fair in 1905.
Fuerst's great-great-grandson Martin now owns the business, which produces around 3.5 million handmade balls annually, still in Salzburg and still using the traditional recipe.
Fuerst chocolates can now be ordered online for delivery across the European Union.
But with rising popularity have come imitators and an array of knockoffs, different fillings, wrappings, names -- and also competing claims and legal disputes.
The Fuerst family had to fight for years for recognition of their "Original Salzburger Mozartkugel" wrapped in silver foil with blue print -- including in the courts -- because their progenitor made the mistake of not protecting his creation in the first place.
Mozart chocolates do not have protected designation of origin status, a European protection for food-related products from certain geographical areas, such as champagne and parmesan cheese.
Even German heavyweight Reber, which produces 500,000 balls daily just across the border from Salzburg, is allowed to call its Mozart balls "authentic", even if it cannot use the term "original".
Contacted by AFP, Mondelez International, formerly known as Kraft Foods, declined to reveal where within its "European network" it began manufacturing the newly launched "Authentic Mirabell Mozartkugeln" in April.
For decades, the group's chocolates had been made at a plant in Salzburg -- but the facility closed last year after teetering on the brink of bankruptcy for years.
Citing high cocoa prices and rising costs for energy, Mondelez said its Mirabell brand was "a real gem" but the weight of the products had to be reduced slightly "to remain competitive".
Mondelez's Mozart balls currently sell for about $0.50 apiece, while one of Leschanz's handmade confections costs more than seven times that amount.
The Pro-Ge trade union, representing more than 60 workers laid off when the Salzburg plant closed, criticised Mondelez's "lack of transparency" about its new production site.
"The supply chain of an egg can be traced better than that," it said.
- 'Flagship product' -
Viennese chocolatier Heindl also voiced concern about Austria's emblematic confection being produced "somewhere in Eastern Europe".
"The Mozartkugel is a flagship product of Austria, just like the Sachertorte chocolate cake or the apple strudel or the poppy seed strudel," managing director Andreas Heindl, 63, told AFP.
"When someone comes to Austria, they want to take Austrian products home with them, especially when it's Mozartkugeln," said Heindl, whose father founded the firm.
He said he could not imagine moving production abroad to save money, even with cocoa prices tripling hitting businesses hard.
Leschanz likened Mozart balls produced outside Austria to a "souvenir cup emblazoned with Mozart's portrait" that is bought in haste only for the purchaser to discover it says "Made in China" on the bottom.
kym/jza/gil/rl/fec
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Advicenne Receives Marketing Authorization and Reimbursement for Sibnayal® in Saudi Arabia
Advicenne Receives Marketing Authorization and Reimbursement for Sibnayal® in Saudi Arabia

Business Wire

timean hour ago

  • Business Wire

Advicenne Receives Marketing Authorization and Reimbursement for Sibnayal® in Saudi Arabia

PARIS--(BUSINESS WIRE)--Regulatory News: Advicenne (Euronext Growth® - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases, obtains marketing authorization (MA) and reimbursement status for Sibnayal® (a fixed combination of potassium citrate and potassium bicarbonate) in the Kingdom of Saudi Arabia (KSA). Marketing authorization for Sibnayal® (ADV7103) in distal Renal Tubular Acidosis (dRTA) in KSA has been granted, based on the European registration dossier. Furthermore, Saudi authorities have agreed a reimbursement rate in line with the best European pricing. This achievment results of a close collaboration between Advicenne and its local partner, Taïba Healthcare, a leading distributor of pharmaceutical products in the Gulf region. Advicenne will act as the marketing authorization holder, while Taïba Healthcare will manage local marketing activities. The incidence of dRTA is higher in Gulf countries than in Europe or the United States, and prevalence in KSA could be estimated around 600 to 800 patients. Sibnayal® is already prescribed through early access programs in several Gulf countries outside Saudi Arabia. This milestone paves the way for registrations in GCC countries where the application is filed. Didier Laurens, CEO of Advicenne, declared: 'I am particularly proud of this important achievement and wish to congratulate both Advicenne and Taïba Healthcare teams, whose efforts were instrumental in informing and convincing the Saudi health authorities. The reimbursement obtained, comparable to the highest levels recorded in Europe, further attests to the significant therapeutic value of Sibnayal® in a region with one of the highest prevalence rates of dRTA worldwide.' About Advicenne Advicenne (Euronext: ALDVI) is a specialty pharmaceutical company founded in 2007, specializing in the development of innovative treatments in Nephrology. Its lead product Sibnayal® (ADV7103) has received its Marketing Approval for distal renal tubular acidosis in EU and GB. ADV7103 is currently in late-stage development in cystinuria in Europe and in dRTA and cystinuria in the US and in Canada. Headquartered in Paris, Advicenne, listed on the Euronext Paris stock exchange since 2017, has now been listed on Euronext Growth Paris since its transfer on March 30, 2022. For additional information, see: Disclaimer This press release contains certain forward-looking statements concerning Advicenne group and its business, including its prospects and product candidate development. Such forward-looking statements are based on assumptions that Advicenne considers to be reasonable. However, there can be no assurance that the estimates contained in such forward-looking statements will be verified, which estimates are subject to numerous risks including the risks set forth in the 2024 Universal Registration Document filed with the French financial market authority on April 29, 2025 (a copy of which is available on and to the development of economic conditions, financial markets and the markets in which Advicenne operates. The forward-looking statements contained in this press release are also subject to risks not yet known to Advicenne or not currently considered material by Advicenne. The occurrence of all or part of such risks could cause actual results, financial conditions, performance, or achievements of Advicenne to be materially different from such forward-looking statements. Advicenne expressly declines any obligation to update such forward-looking statements.

European stocks set to rise after the U.S. and EU strike trade agreement
European stocks set to rise after the U.S. and EU strike trade agreement

CNBC

timean hour ago

  • CNBC

European stocks set to rise after the U.S. and EU strike trade agreement

Good morning from London. There's just under an hour and a half to go until stocks begin trading for the first time since the U.S. and European Union agreed to a trade deal. Futures tied to the Stoxx Europe 600 index point to a strong start with the index expected to open 0.8% higher. Regionally, the German DAX is expected to rise 1%, France CAC 40 index is set to be 0.4% higher and the U.K.'s FTSE 100 is expected to rise 0.5%. — Ganesh Rao

Asian shares are mixed after Wall Street sets more records for US stocks
Asian shares are mixed after Wall Street sets more records for US stocks

The Hill

timean hour ago

  • The Hill

Asian shares are mixed after Wall Street sets more records for US stocks

BANGKOK (AP) — Stock markets in Asia were mixed on Monday after U.S. stocks rose to more records as they closed out another winning week. U.S. futures and oil prices were higher ahead of trade talks in Stockholm between U.S. and Chinese officials. European futures rose after the European Union forged a deal with the Trump administration calling for 15% tariffs on most exports to the U.S. The agreement announced after President Donald Trump and European Commission chief Ursula von der Leyen met briefly at Trump's Turnberry golf course in Scotland staves off far higher import duties on both sides that might have sent shock waves through economies around the globe. Tokyo's Nikkei 225 index lost 1% to 41,056.81 after doubts surfaced over what exactly the trade truce between Japan and U.S. President Donald Trump, especially the $550 billion pledge of investment in the U.S. by Japan, will entail. Terms of the deal are still being negotiated and nothing has been formalized in writing, said an official, who insisted on anonymity to detail the terms of the talks. The official suggested the goal was for a $550 billion fund to make investments at Trump's direction. Hong Kong's Hang Seng index gained 0.4% to 25,490.45 while the Shanghai Composite index lost 0.2% to 3,587.25. Taiwan's Taiex rose 0.3%. CK Hutchison, a Hong Kong conglomerate that's selling ports at the Panama Canal, said it may seek a Chinese investor to join a consortium of buyers in a move that might please Beijing but could also bring more U.S. scrutiny to a geopolitically fraught deal. CK Hutchison's shares fell 0.6% on Monday in Hong Kong. Elsewhere in Asia, South Korea's Kospi was little changed at 3,195.49, while Australia's S&P/ASX 200 rose 0.3% to 8,688.40. India's Sensex slipped 0.1%. Markets in Thailand were closed for a holiday. On Friday, the S&P 500 rose 0.4% to 6,388.64, setting an all-time for the fifth time in a week. The Dow Jones Industrial Average climbed 0.5% to 44,901.92, while the Nasdaq composite added 0.2%, closing at 21,108.32 to top its own record. Deckers, the company behind Ugg boots and Hoka shoes, jumped 11.3% after reporting stronger profit and revenue for the spring than analysts expected. Its growth was particularly strong outside the United States, where revenue soared nearly 50%. But Intell fell 8.5% after reporting a loss for the latest quarter, when analysts were looking for a profit. The struggling chipmaker also said it would cut thousands of jobs and eliminate other expenses as it tries to turn around its fortunes. Intel, which helped launch Silicon Valley as the U.S. technology hub, has fallen behind rivals like Nvidia and Advanced Micro Devices while demand for artificial intelligence chips soars. Companies are under pressure to deliver solid growth in profits to justify big gains for their stock prices, which have rallied to record after record in recent weeks. Wall Street has zoomed higher on hopes that President Donald Trump will reach trade deals with other countries that will lower his stiff proposed tariffs, along with the risk that they could cause a recession and drive up inflation. Trump has recently announced deals with Japan and the Philippines, and the next big deadline is looming on Friday, Aug. 1. Apart from trade talks, this week will also feature a meeting by the Federal Reserve on interest rates. Trump again on Thursday lobbied the Fed to cut rates, which he has implied could save the U.S. government money on its debt repayments. Fed Chair Jerome Powell has said he is waiting for more data about how Trump's tariffs affect the economy and inflation before making a move. The widespread expectation on Wall Street is that the Fed will wait until September to resume cutting interest rates. In other dealings early Monday, U.S. benchmark crude oil gained 24 cents to $65.40 per barrel. Brent crude, the international standard, also added 24 cents to $67.90 per barrel. The dollar rose to 147.72 Japanese yen from 147.71 yen. The euro slipped to $1.1755 from $1.1758.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store